» Articles » PMID: 32157102

A Novel Accurate LC-MS/MS Method for Quantitative Determination of Z-lumirubin

Overview
Journal Sci Rep
Specialty Science
Date 2020 Mar 12
PMID 32157102
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Although phototherapy (PT) is a standard treatment for neonatal jaundice, no validated clinical methods for determination of bilirubin phototherapy products are available. Thus, the aim of our study was to establish a such method for clinical use. To achieve this aim, a LC-MS/MS assay for simultaneous determination of Z-lumirubin (LR) and unconjugated bilirubin (UCB) was conducted. LR was purified after irradiation of UCB at 460 nm. The assay was tested on human sera from PT-treated neonates. Samples were separated on a HPLC system with a triple quadrupole mass spectrometer detector. The instrument response was linear up to 5.8 and 23.4 mg/dL for LR and UCB, respectively, with submicromolar limits of detection and validity parameters relevant for use in clinical medicine. Exposure of newborns to PT raised serum LR concentrations three-fold (p < 0.01), but the absolute concentrations were low (0.37 ± 0.16 mg/dL), despite a dramatic decrease of serum UCB concentrations (13.6 ± 2.2 vs. 10.3 ± 3.3 mg/dL, p < 0.01). A LC-MS/MS method for the simultaneous determination of LR and UCB in human serum was established and validated for clinical use. This method should help to monitor neonates on PT, as well as to improve our understanding of both the kinetics and biology of bilirubin phototherapy products.

Citing Articles

Efficacy of phototherapy of neonatal jaundice - light wavelength matters.

Vitek L, Tiribelli C Pediatr Res. 2024; .

PMID: 39604521 DOI: 10.1038/s41390-024-03750-y.


Risk of childhood cancer in infants treated with phototherapy for neonatal jaundice.

Vitek L Pediatr Res. 2024; 96(5):1105-1106.

PMID: 38858505 DOI: 10.1038/s41390-024-03315-z.


Noninvasive monitoring of bilirubin photoisomer excretion during phototherapy.

Uchida Y, Takahashi Y, Morimoto Y, Greimel P, Tosaki A, Kumagai A Sci Rep. 2022; 12(1):11798.

PMID: 35821401 PMC: 9276810. DOI: 10.1038/s41598-022-16180-9.


The Effects of Bilirubin and Lumirubin on the Differentiation of Human Pluripotent Cell-Derived Neural Stem Cells.

Capkova N, Pospisilova V, Fedorova V, Raska J, Pospisilova K, Dal Ben M Antioxidants (Basel). 2021; 10(10).

PMID: 34679668 PMC: 8532948. DOI: 10.3390/antiox10101532.


Diagnostic methods for neonatal hyperbilirubinemia: benefits, limitations, requirements, and novel developments.

Hulzebos C, Vitek L, Coda Zabetta C, Dvorak A, Schenk P, van der Hagen E Pediatr Res. 2021; 90(2):277-283.

PMID: 33948000 DOI: 10.1038/s41390-021-01546-y.


References
1.
Bhutani V, Gourley G, Adler S, Kreamer B, Dalin C, Johnson L . Noninvasive measurement of total serum bilirubin in a multiracial predischarge newborn population to assess the risk of severe hyperbilirubinemia. Pediatrics. 2000; 106(2):E17. DOI: 10.1542/peds.106.2.e17. View

2.
Stoll M, Zenone E, Ostrow J, Zarembo J . Preparation and properties of bilirubin photoisomers. Biochem J. 1979; 183(1):139-46. PMC: 1161482. DOI: 10.1042/bj1830139. View

3.
CREMER R, PERRYMAN P, Richards D . Influence of light on the hyperbilirubinaemia of infants. Lancet. 1958; 1(7030):1094-7. DOI: 10.1016/s0140-6736(58)91849-x. View

4.
Soares D, Andreazza A, Salvador M . Sequestering ability of butylated hydroxytoluene, propyl gallate, resveratrol, and vitamins C and E against ABTS, DPPH, and hydroxyl free radicals in chemical and biological systems. J Agric Food Chem. 2003; 51(4):1077-80. DOI: 10.1021/jf020864z. View

5.
Vreman H, Wong R, Stevenson D . Phototherapy: current methods and future directions. Semin Perinatol. 2005; 28(5):326-33. DOI: 10.1053/j.semperi.2004.09.003. View